[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614592":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":99,"collaborators":27,"id":101,"slug":27,"hasResults":102,"nctId":103,"briefTitle":104,"officialTitle":104,"acronym":105,"eligibilityCriteria":106,"healthyVolunteers":107,"sex":108,"minAge":109,"maxAge":27,"enrollmentInfo":110,"targetDuration":27,"studyType":113,"phases":114,"briefSummary":116,"conditions":117,"keywords":129,"overallStatus":38,"whyStopped":27,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":147,"completionDateStruct":149,"leadSponsor":151,"locationsCount":152},{"fullName":5,"class":6},"Qurasense","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Non-invasive, passive self-collection \u002F Clinician collection","OTHER","Participants referred for colposcopy after abnormal cervical screening will collect menstrual blood at home using the Q-Pad kit and mail the sample for hrHPV testing. At the colposcopy visit, they will have a clinician-collected cervical specimen obtained for hrHPV testing and undergo colposcopy with biopsy as part of standard care.",[13],"Device: Q-Pad hrHPV Test System",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Q-Pad hrHPV Test System","Participants will receive a mailed Q-Pad Kit, which includes two Q-Pads (menstrual pads with removable collection strips called Q-Strips), a Q-Strip Container with desiccant for storing and shipping the strips, and a prepaid return mailer. During the menstrual cycle after their colposcopy visit, participants will follow the Instructions for Use to passively collect menstrual blood with the Q-Pads, then remove the Q-Strips and place them in the Q-Strip Container for mailing to the central laboratory for hrHPV testing. At the colposcopy visit, the clinician will also collect a cervical sample in ThinPrep liquid-based cytology medium for hrHPV testing, which will serve as the comparator specimen.",[9],[21,22,23],"Q-Pad Kit","Colposcopy","Clinician collection",[25],{"name":26,"affiliation":27,"role":28},"Paul Blumenthal, MD, MPH",null,"STUDY_DIRECTOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":27,"email":34},"Brian Weinberg, MS","CONTACT","833-367-7846","care@qvin.com",[36,54,69,84],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Planned Parenthood of Southern New England","RECRUITING","New Haven","Connecticut","06511","United States",{"type":44,"coordinates":45},"Point",[46,47],-72.92816,41.30815,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":52,"phoneExt":27,"email":53},"Danielle Salinas, MSCR","203-903-0394","danielle.salinas@ppsne.org",{"facility":55,"status":38,"city":56,"state":57,"zip":58,"country":42,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Planned Parenthood North Central States","Minneapolis","Minnesota","55408",{"type":44,"coordinates":60},[61,62],-93.26384,44.97997,{"lat":62,"lon":61},[65],{"name":66,"role":32,"phone":67,"phoneExt":27,"email":68},"Bridge McKye, MPH","651-389-0675","bmckye@ppncs.org",{"facility":70,"status":38,"city":71,"state":72,"zip":73,"country":42,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Planned Parenthood of Greater Ohio (PPGOH)","Akron","Ohio","44302",{"type":44,"coordinates":75},[76,77],-81.51901,41.08144,{"lat":77,"lon":76},[80],{"name":81,"role":32,"phone":82,"phoneExt":27,"email":83},"Penny Paxton","440-279-8109","penny.paxton@ppoh.org",{"facility":85,"status":38,"city":86,"state":87,"zip":88,"country":42,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Planned Parenthood Association of Utah","Salt Lake City","Utah","84102",{"type":44,"coordinates":90},[91,92],-111.89105,40.76078,{"lat":92,"lon":91},[95],{"name":96,"role":32,"phone":97,"phoneExt":27,"email":98},"Priscila Monteiro, MS, MBA","385-355-1875","Priscila.Monteiro@ppau.org",{"type":100,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100614592",false,"NCT07281599","Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer","EQUIP","Inclusion Criteria:\n\n* You are 25 years old or older and have an intact cervix.\n* You were referred for a colposcopy after an abnormal Pap or HPV screen.\n* Your periods come regularly-about every 21-35 days.\n* You own a smartphone, have an email address, and can read the Qvin app instructions in English.\n* You are willing to sign the consent form (electronically).\n* You agree to use a condom for any vaginal intercourse or shared penetrative toy use from Q-Pad collection until the colposcopy visit if engaging with a new sexual partner during this period.\n\nExclusion Criteria:\n\n* You are pregnant or think you might be.\n* You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).\n* You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.\n* You have already joined this study or are in another cervical-screening \u002F HPV study right now.",true,"FEMALE","25 Years",{"count":111,"type":112},450,"ESTIMATED","INTERVENTIONAL",[115],"NA","The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing.\n\nThe same participants will have a standard cervical sample collected for routine hrHPV testing and will undergo colposcopy as part of their usual care. By comparing hrHPV results from menstrual samples with results from cervical samples and biopsy findings, the study will evaluate how well the Q-Pad hrHPV Test System detects cervical precancer and will also assess how easy and acceptable it is for participants to use this at-home collection method.",[118,119,120,121,122,123,124,125,126,127,128],"HPV Infection","HPV 16 Infection","High Risk HPV","Cervical Cancer Screening","Cervical Cancer Cin Grade","Cervical Cancer (Early Detection)","HPV","HPV (Human Papillomavirus)-Associated","HPV DNA","HPV Infections","Screening Test",[130,131,132,133,134,135,136,137,138,139,124,140,141,142],"Q-Pad","Self-sampling","Self-collection","self-collect","cervical cancer screening","menstural blood","Sexually Transmitted Diseases, Viral","Sexually Transmitted Diseases","Genital Diseases","Papillomavirus Infections","high risk HPV","pap smear","at-home collection","2026-01-29",{"date":145,"type":146},"2026-02-02","ACTUAL",{"date":148,"type":146},"2025-12-01",{"date":150,"type":112},"2027-03",{"name":5,"class":6},4]